当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Maria Tiwari
Recently, a number of outstanding review articles covering a wide range of scientific and technological elements of bioanalysis have been published in the literature. Today, it is widely recognised that bioanalysis is essential for characterising novel chemical entities’ pharmacokinetic/pharmacodynamic properties, both at the time of their discovery and during the various stages of drug development that result in their approval for use in the marketplace. This collection examines important bioanalytical standards and how drug research and discovery processes might use them to produce safer, more affordable drugs. It is intended to offer some overarching concepts in this area that will act as the cornerstone of an all-encompassing framework for approaching bioanalysis from the inception (i.e., the identification of a lead molecule) and progressing through various phases of drug development.